Statin withdrawal beyond acute phase affected outcome of thrombolytic stroke patients

Medicine (United States)

Volumn 94, Issue 17, 2015, Pages e779-

  Tong, Lu Sha ^a   Hu, Hai Tao ^a   Zhang, Sheng ^a   Yan, Shen Qiang ^a   Lou, Min ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ATORVASTATIN; CHOLESTEROL; FIBRINOLYTIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CARDIOEMBOLIC STROKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DEATH; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SIDE EFFECT; SMOKING; STROKE PATIENT; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

AGED; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME;

EID: 84937511491     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000779     Document Type: Article

References (30)

1. Chen J, Zhang ZG, Li Y, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003;53:743-751.
2. Fisher M, Moonis M. Neuroprotective effects of statins: evidence from preclinical and clinical studies. Curr Treat Options Cardiovasc Med. 2012;14:252-259.
3. Flint AC, Kamel H, Navi BB, et al. Inpatient statin use predicts improved ischemic stroke discharge disposition. Neurology. 2012;78:1678-1683.
4. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology. 2007;69:904-910.
5. Chroinin DN, Asplund K, Asberg S, et al. Statin therapy and outcome after ischemic stroke systematic review and meta-analysis of observational studies and randomized trials. Stroke. 2013;44: 448-456.
6. Cappellari M, Bovi P, Moretto G, et al. The THRombolysis and STatins (THRaST) study. Neurology. 2013;80:655-661.
7. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275-282.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
9. Engelter ST, Soinne L, Ringleb P, et al. IV thrombolysis and statins. Neurology. 2011;77:888-895.
10. Daskalopoulou SS, Delaney JA, Filion KB, et al. Discontinuation of statin therapy following an acute myocardial infarction: a population- based study. Eur Heart J. 2008;29:2083-2091.
11. Gomez Sandoval YH, Braganza MV, Daskalopoulou SS. Statin discontinuation in high-risk patients: a systematic review of the evidence. Curr Pharm Des. 2011;17:3669-3689.
12. Kim MC, Cho JY, Jeong HC, et al. Impact of postdischarge statin withdrawal on long-term outcomes in patients with acute myocardial infarction. Am J Cardiol. 2015;115:1-7.
13. Laufs U, Endres M, Custodis F, et al. Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation. 2000;102:3104-3110.
14. Heeschen C, Hamm CW, Laufs U, et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002;105:1446-1452.
15. Castejon AM, Zollner E, Tristano AG, et al. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells. J Cardiovasc Pharmacol. 2007;50:708-711.
16. Li JJ, Li YS, Chu JM, et al. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. Clinica Chim Acta. 2006;366:269-273.
17. Li JJ. Inflammatory rebound phenomenon after abrupt withdrawal of statin is a mature point of view but not hypotheses. Int J Cardiol. 2011;151:120.
18. Jaipersad AS, Shantsila E, Blann A, et al. The effect of statin therapy withdrawal on monocyte subsets. Eur J Clin Invest. 2013;43:1307-1313.
19. Teixeira MZ. Statins withdrawal, vascular complications, rebound effect and similitude. Homeopathy. 2010;99:255-262.
20. Hermann DM, Chopp M. Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 2012;11:369-380.
21. Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. Inflammation in ischemic stroke subtypes. Curr Pharm Des. 2012;18:4289-4310.
22. Ohira T, Shahar E, Iso H, et al. Carotid artery wall thickness and risk of stroke subtypes: the atherosclerosis risk in communities study. Stroke. 2011;42:397-403.
23. Bourcier T, Libby P. HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20:556-562.
24. Tsai NW, Lin TK, Chang WN, et al. Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke. Crit Care. 2011:15.
25. Campos M, Garcia-Bonilla L, Hernandez-Guillamon M, et al. Combining statins with tissue plasminogen activator treatment after experimental and human stroke: a safety study on hemorrhagic transformation. CNS Neurosci Ther. 2013;19:863-870.
26. Fassbender K, Dempfle CE, Mielke O, et al. Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator. Stroke. 1999;30:2101-2104.
27. Cubeddu LX, Seamon MJ. Statin withdrawal: clinical implications and molecular mechanisms. Pharmacotherapy. 2006;26:1288-1296.
28. Lai WT, Lee KT, Chu CS, et al. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation. Int J Cardiol. 2005;98:459-464.
29. Daskalopoulou SS. When statin therapy stops: implications for the patient. Curr Opin Cardiol. 2009;24:454-460.
30. Altman IM, Swick S, Malec JF. Effectiveness of home- and community-based rehabilitation in a large cohort of patients disabled by cerebrovascular accident: evidence of a dose-response relationship. Arch Phys Med Rehabil. 2013;94:1837-1841.